- Home
- GIGM vs HBIO Comparison
GIGM vs HBIO Comparison
Compare GIGM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- HBIO
- Stock Information
- Founded
- GIGM 1998
- HBIO 1901
- Country
- GIGM Taiwan
- HBIO United States
- Employees
- GIGM N/A
- HBIO N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- GIGM Technology
- HBIO Industrials
- Exchange
- GIGM Nasdaq
- HBIO Nasdaq
- Market Cap
- GIGM 16.1M
- HBIO 24.6M
- IPO Year
- GIGM 2000
- HBIO 2000
- Fundamental
- Price
- GIGM $1.43
- HBIO $0.48
- Analyst Decision
- GIGM
- HBIO Buy
- Analyst Count
- GIGM 0
- HBIO 2
- Target Price
- GIGM N/A
- HBIO $3.00
- AVG Volume (30 Days)
- GIGM 6.7K
- HBIO 1.1M
- Earning Date
- GIGM 08-12-2025
- HBIO 08-11-2025
- Dividend Yield
- GIGM N/A
- HBIO N/A
- EPS Growth
- GIGM N/A
- HBIO N/A
- EPS
- GIGM N/A
- HBIO N/A
- Revenue
- GIGM $3,103,000.00
- HBIO $91,397,000.00
- Revenue This Year
- GIGM N/A
- HBIO N/A
- Revenue Next Year
- GIGM N/A
- HBIO $9.75
- P/E Ratio
- GIGM N/A
- HBIO N/A
- Revenue Growth
- GIGM N/A
- HBIO N/A
- 52 Week Low
- GIGM $1.28
- HBIO $0.28
- 52 Week High
- GIGM $1.80
- HBIO $3.42
- Technical
- Relative Strength Index (RSI)
- GIGM 46.68
- HBIO 49.65
- Support Level
- GIGM $1.40
- HBIO $0.39
- Resistance Level
- GIGM $1.48
- HBIO $0.64
- Average True Range (ATR)
- GIGM 0.05
- HBIO 0.05
- MACD
- GIGM 0.00
- HBIO 0.00
- Stochastic Oscillator
- GIGM 18.87
- HBIO 34.80
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.